Neogen reported robust Q1 FY27 results with 34% revenue growth and 53% EBITDA growth. Strategy pivots toward battery materials and organo-lithium, supported by a ₹600 crore QIP for de-leveraging.
Neogen reported robust Q1 FY27 results with consolidated revenue growing 34% and PAT up 67% YoY. Growth was driven by the Organolithium portfolio and the ramp-up of Neogen Ionics.
Neogen reported Q4 FY26 revenue of ₹247 crore (+22% YoY) and EBITDA of ₹44 crore (+21% YoY). The company is transitioning towards a battery materials-led portfolio with massive capex in Pakhajan and Dahej.
Neogen delivered volume-led Q4 growth but faces significant execution hurdles as battery project costs ballooned by ₹250cr+ while timelines shifted to the right.